Stay updated on Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial

Sign up to get notified when there's something new on the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4. This indicates a small platform or content update rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-07-25T10:29:59.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page now displays a new revision label 'Revision: v3.6.3'. This replaces the previous 'Revision: v3.6.2' and indicates a version update of the page content.
    Difference
    0.1%
    Check dated 2026-07-03T22:53:12.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Revision label on the page footer was updated from v3.6.0 to v3.6.2, indicating a newer platform version. This update does not modify the study details or visible content.
    Difference
    0.1%
    Check dated 2026-06-27T01:04:34.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    A recruitment-closed banner is now displayed on the page. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) are added, and a formatting change updates 'Intervention / Treatment' to 'Intervention/Treatment' along with a revision stamp to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:28:38.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    Page revision tag updated from v3.5.4 to v3.5.5, indicating a maintenance/patch-level update to the page. This change does not alter the visible content or behavior of the page.
    Difference
    0.1%
    Check dated 2026-06-05T12:33:53.000Z thumbnail image
  9. Check
    79 days ago
    Change Detected
    Summary
    The page shows a new revision tag, v3.5.4, replacing the previous v3.5.3, indicating a small update to the document version. The change affects metadata only and does not modify study details or results.
    Difference
    0.1%
    Check dated 2026-05-15T05:57:47.000Z thumbnail image

Stay in the know with updates to Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page.